心臓トロポニンTは,末期腎疾患の患者の死亡率を予測する
J Dierkes1, U Domröse, S Westphal
1Institute of Clinical Chemistry, University Hospital Magdeburg, Germany. jutta.dierkes@medizin.uni-magdeburg.de
Circulation
|October 18, 2000
まとめ
心臓トロポニンTと総ホモシステインは,血液透析患者の死亡率の主要な予測因子です. 心臓のトロポニンT値が上昇すると,死亡リスクが著しく増加し,末期性腎疾患における予後値が強調されます.
科学分野:
- ネフロロジーは腎臓科
- 心臓病学 心臓病学
- 臨床化学 臨床化学について
背景:
- 末期腎疾患 (ESRD) の患者は,主に心血管疾患 (CVD) から高度の早死率に直面しています.
- 従来のリスク要因は,ESRDにおける心血管疾患のリスクの増加を不十分に説明する.
- この研究では,血液透析患者の新しい予後マーカーを調査した.
研究 の 目的:
- ヘモダイアリス患者における全死亡率と心血管疾患を将来的に評価する.
- 病原病状と特定の実験室の変数の予後値を評価する.
- ESRDにおける死亡率と心血管疾患の独立予測要因を特定する.
主な方法:
- 102人の血液透析患者の将来性研究.
- 2年間の追跡調査で,心血管疾患および全死亡率のモニタリングが行われました.
- カプラン・マイヤー生存分析とコックス比例リスクモデリング.
主要な成果:
- 心臓トロポニンT >0.10ng/mLは死亡率の最も強い予測因子でした (HR 6.85).
- トータルホモシステインの上昇 (中位値以上) も死亡率 (HR 2.44) を予測した.
- グルコースとトリグリセリドは,調整後の心血管疾患を独立して予測した.
結論:
- トータルホモシステインと心臓トロポニンTは,ESRD患者における死亡率の有意な予測因子である.
- 心臓のトロポニンTは,死亡率の特に強い予後値を示しています.
- ベースラインの疾患状態およびその他の研究室の変数は,トロポニンTおよびホモシステインと比較して,予後的有用性が限られていることを示しました.
関連する概念動画
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
769
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
582
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
582
01:20Acute Kidney Injury V: Interprofessional Care
548
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
548
01:28Chronic Kidney Disease III: Interprofessional Care
706
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
706
01:18Chronic Kidney Disease IV: Nursing Management
702
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
702